How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

TL

NASDAQ:TLSA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

TL

Tiziana Life Sciences LtdNASDAQ TLSA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is TLSA undervalued compared to its fair value?

The fair value of TLSA stock is hidden USD. Relative to the market price of 0.85 USD Tiziana Life Sciences Ltd is hidden.

Tiziana Life Sciences Ltd. operates as a clinical stage biotechnology company. The firm specializes in developing transformative therapies for neurodegenerative diseases and gastrointestinal diseases. Its clinical pipeli...[More about valuation]

Tiziana Life Sciences Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.088 $B

Price:

0.85 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.103

FINANCIALS

Tiziana Life Sciences financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.01 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.011 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.026 B
0.02 B

Financial Position Analysis

Assets

0.026 B
Current Assets
0.024 B
Total non-current assets
0.0022 B

Total current liabilities
0.0067 B
Total non-current liabilities
0.0003 B

Cash Flow Statement

-0.0078 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0077 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Tiziana Life Sciences fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is TLSA attractive for investment based on fundamental analysis?

TLSA stock rating is hidden. Tiziana Life Sciences is a hidden by Eyestock methodology.

Get TLSA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

TLSA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for TLSA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Tiziana Life Sciences Ltd competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Tiziana Life Sciences Ltd dividends

TLSA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About TLSA stock

About the company Tiziana Life Sciences Ltd

Market cap $B

0.088

Dividend yield

Shares outstanding

194.612 B

Website

Tiziana Life Sciences Ltd. operates as a clinical stage biotechnology company. The firm specializes in developing transformative therapies for neurodegenerative diseases and gastrointestinal diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Crohn's Disease and KRAS+ NSCLC. The Company’s lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Crohn's disease, Pro-MS and autoimmune diseases, and its Milciclib (TZLS-201), is an orally bioavailable, small molecule, spectrum inhibitor of cyclin-dependent kinases (CDKs) (a family of highly conserved enzymes that regulate the cell cycle and cell division) and Src family kinases, which involved in regulating cell growth and potential transformation of normal cells to cancer cells. The firm is also focused on Anti Interlukin-6 Receptor mAB (TZLS-501), which is a fully human mAb that binds to both membrane-bound and soluble forms of IL-6R.

TLSA profile

  • Ticker

    TLSA

  • Country

    Great Britain

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    14 July 2008

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    14

  • City

    London

  • Address

    3Rd Floor, 11-12 St. James's Square

  • Cusip

    G88912103